secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001380106-24-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Q4 rev ~$6.2-6.4M (+45%); FY rev ~$22.4-22.6M (+30%); cash $95M runway into H2 2026
--------------------------------------------------------------------------------

- Q4 revenue expected $6.2-6.4M (+45% YoY); FY23 revenue $22.4-22.6M (+30% YoY).
- Placed 16 Growth Direct systems in FY23, 6 in Q4; 18 validations completed in FY23.
- Cash and investments ~$95M as of Dec 31, 2023; cash runway at least into H2 2026.
- Growth Direct selected by Samsung Biologics; systems now placed with 100% of commercial CAR-T manufacturers.
- Commercial launch of Growth Direct Rapid Sterility app expected by mid-2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010624000009/0001380106-24-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010624000009/rpid-20240110.htm
  HTML page:      https://secwatch.observer/filing/0001380106-24-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer